Analyst Research Report Snapshot

Title:

MEDICX FUND LIMITED - ON THE GROWTH TRAIL

Price:

$10.00

Provider:

Edison Investment Research

Date:

17 Dec 2009

Pages:

12

Type:

AcrobatPDF

Companies referenced:

MXF.L

Available for Immediate Download
Summary:

The business model proved resilient to the challenges posed in FY09, with further organic growth and an increase in the rent roll to £11.7m pa. MedicX ended FY09 with a fully let portfolio, finances intact and renewed ambition for more expansive growth in FY10e. The outlook is supported by potential revenue growth on the back of rent reviews and asset management, plus earnings enhancing acquisitions and a 40% cut in overheads. The shares are below all-in FY09 NAV, underpinned by a 7.5% yield and Edison’s 90p DCF value of a secure, visible rental stream. FOR MORE INFORMATION ON THE ATTACHED RESEARCH PLEASE CALL 020 3077 5700, EMAIL RESEARCH@EDISONINVESTMENTRESEARCH.CO.UK OR VISIT WWW.EDISONINVESTMENTRESEARCH.CO.UK

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.